Concepedia

Author

Antonio Tedeschi

Research Institute of Molecular PathologyORCID

Also Known As

A Tedeschi, Antonio Tedeschi

34

Publications

1.7K

Citations

10

H-Index

37

Concepts

All Affiliations

Research Institute of Molecular PathologyBoehringer Ingelheim (Austria)National Research CouncilInstitute of Molecular Biology and PathologyAustrian Academy of Sciences
AT

About

Antonio Tedeschi is an author at Research Institute of Molecular Pathology specializing in medicine, cell biology, and chromatin.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

1.1K

2

Cell Biology

5

5

623

3

Natural Sciences

3

3

950

4

Cellular Physiology

1

1

58

5

Immunology

1

1

100

Antonio Tedeschi

×

9

Publications

1.2K

Citations

9

H-Index

YearCitations

Cohesin is positioned in mammalian genomes by transcription, CTCF and Wapl

Georg Busslinger, Roman R. Stocsits, Petra van der Lelij,

Nature

2017

501

Wapl is an essential regulator of chromatin structure and chromosome segregation

Antonio Tedeschi, Gordana Wutz, Sébastien Huet,

Nature

2013

391

Antigen retrieval and clearing for whole-organ immunofluorescence by FLASH

Hendrik A. Messal, Jorge Almagro, May Zaw Thin,

Nature Protocols

2020

100

RANBP1 localizes a subset of mitotic regulatory factors on spindle microtubules and regulates chromosome segregation in human cells

Antonio Tedeschi, Marilena Ciciarello, Rosamaria Mangiacasale,

Journal of Cell Science

2007

58

Cep55 promotes cytokinesis of neural progenitors but is dispensable for most mammalian cell divisions

Antonio Tedeschi, Jorge Almagro, Matthew J. Renshaw,

Nature Communications

2020

54

Wapl releases Scc1-cohesin and regulates chromosome structure and segregation in mouse oocytes

Mariana C.C. Silva, Sean Powell, Sabrina Ladstätter,

The Journal of Cell Biology

2020

38

RanBP1 downregulation sensitizes cancer cells to taxol in a caspase-3-dependent manner

Whilelmina Maria Rensen, Emanuele Roscioli, Antonio Tedeschi,

Oncogene

2009

36

Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele Amplification

Antonio Tedeschi, Fiorella Schischlik, Francesca Rocchetti,

Molecular Cancer Therapeutics

2024

14

Abstract 3317: KRASmulti inhibitor BI 3706674 shows efficacy in KRAS-driven preclinical models of cancer that supports clinical testing in patients with tumors harbouring KRASG12V mutations and KRAS wild-type amplifications

Antonio Tedeschi, David H. Peng, Fiorella Schischlik,

Cancer Research

2024

13

Page 1